TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA-Reference-Cited by-同舟云学术

TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA

Published:2001-06 Issue:3 Volume:81 Page:683-690
ISSN:0039-6109
Container-title:Surgical Clinics of North America
language:en
Short-container-title:Surgical Clinics of North America

Author:

Kozuch Peter,Petryk Magdalena,Evans Andrew,Bruckner Howard W.

Publisher

Elsevier BV

Subject

Surgery

Reference52 articles.

1. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM);Bitran;Cancer Treat Rep,1979

2. Pneumocystis carinii pneumonia in non-small cell lung cancer patients treated with combination gemcitabine and vinorelbine therapy [abstract 1919];Blumenschein;Proc Am Soc Clin Oncol,1999

3. Schedule-dependent antitumor effect of gemcitabine in in vivo model system [abstract];Braakhuis;Eur J Cancer,1995

4. Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusion;Bruckner;Oncology,1989

5. Phase II trial of combination chemotherapy for pancreatic cancer with 5-fluorouracil, mitomycin C, and hexamethylmelamine;Bruckner;Oncology,1983

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI of the Pancreaticobiliary System;Fundamentals of Body MRI;2012

2. MRI of the Bile Ducts, Gallbladder, and Pancreas;Body MRI;2005

3. Non-toxic and short treatment with gemcitabine inhibits in vitro migration of HT-1080 cells;Anti-Cancer Drugs;2004-09

4. Pancreatic Cancer: Evidence-Based Diagnosis and Treatment;Clinical Obstetrics and Gynecology;2002-09

5. Exploiting molecular targets in pancreatic cancer;Hematology/Oncology Clinics of North America;2002-02